Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Ron Kline who wrote (4799)	7/7/1998 11:23:00 AM
From: Steve Fancy	Respond to of 6136

Subject: Re: Investor Relations questions Date: 7 Jul 1998 07:20:11 -0800 Reply to: RE>Investor Relations questions 1) Please advise of the date that AGPH will report 4Q '98 earnings. JULY 21ST, MARKET CLOSE 2) An analyst report released today read as if they received guidance from AGPH regarding payment dates of upfront licensing fees for the three compounds AGPH recently inlicensed. Please advise if these payments are all being taken against your most recent completed quarter. I HAVE NO KNOWLEDGE OF ANY INFORMATION GIVEN TO AN ANALYST ON PAYMENT DATES. THIS IS NOT PUBLIC TO MY KNOWLEDGE. BUT I'LL CHECK FOR YOU TO BE SURE.